863,260 Shares in Kenvue Inc. (NYSE:KVUE) Acquired by Ilex Capital Partners UK LLP

Ilex Capital Partners UK LLP acquired a new position in shares of Kenvue Inc. (NYSE:KVUE) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 863,260 shares of the company’s stock, valued at approximately $19,967,000. Kenvue accounts for approximately 1.3% of Ilex Capital Partners UK LLP’s portfolio, making the stock its 23rd largest position.

Other hedge funds have also recently added to or reduced their stakes in the company. Riverview Trust Co bought a new position in Kenvue during the 3rd quarter worth $30,000. Ashton Thomas Securities LLC bought a new position in Kenvue during the 3rd quarter worth $35,000. Deseret Mutual Benefit Administrators increased its stake in shares of Kenvue by 49.7% in the 3rd quarter. Deseret Mutual Benefit Administrators now owns 1,960 shares of the company’s stock valued at $45,000 after purchasing an additional 651 shares during the last quarter. Studio Investment Management LLC increased its stake in shares of Kenvue by 52.1% in the 2nd quarter. Studio Investment Management LLC now owns 2,468 shares of the company’s stock valued at $45,000 after purchasing an additional 845 shares during the last quarter. Finally, Brooklyn Investment Group bought a new position in shares of Kenvue in the 3rd quarter valued at $71,000. Institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on KVUE. JPMorgan Chase & Co. lifted their price target on Kenvue from $24.00 to $25.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Royal Bank of Canada lowered Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price target on the stock. in a research note on Tuesday, September 24th. Bank of America lifted their price target on Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Tuesday, October 22nd. Jefferies Financial Group initiated coverage on Kenvue in a research note on Tuesday, September 24th. They issued a “buy” rating and a $27.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $22.64.

Kenvue Trading Down 1.4 %

Shares of NYSE KVUE traded down $0.33 during trading on Tuesday, reaching $23.93. The company had a trading volume of 825,675 shares, compared to its average volume of 17,716,770. The stock has a market cap of $45.88 billion, a P/E ratio of 44.15, a PEG ratio of 2.19 and a beta of 1.37. The company’s fifty day moving average price is $22.96 and its 200-day moving average price is $21.02. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, November 7th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.27 by $0.01. The business had revenue of $3.90 billion for the quarter, compared to analysts’ expectations of $3.92 billion. Kenvue had a return on equity of 21.43% and a net margin of 6.88%. The firm’s revenue was down .4% on a year-over-year basis. During the same period in the prior year, the business posted $0.31 earnings per share. As a group, research analysts expect that Kenvue Inc. will post 1.07 earnings per share for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 27th. Stockholders of record on Wednesday, November 13th were given a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.43%. Kenvue’s dividend payout ratio (DPR) is currently 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.